Gregory Seidensticker, MD
Hospice and Palliative Medicine · Columbus, OHNPI 1457384307
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,096 of the $7,259 with a category attached, or 84.0%. 28 manufacturers reported payments, led by Medtronic at 38.7% of the total. 2025 is the largest year on record at $2,754, 5.2 times the $529 reported in 2019. Among hospice and palliative medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 318 payments — averaging $22.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- AbbVie$1K
- Collegium Pharmaceutical, Inc.$565
- Pfizer$502
- Nevro Corp.$246
- Biohaven Pharmaceutical Holding Company Ltd.$231
- plus $1K from 22 others
What the payments were for
- Travel & lodging$1,11315%
- Food & beverage$6,09684%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 44 | $2,806 |
| AbbVie(2 entities) | 91 | $1,424 |
| Collegium Pharmaceutical, Inc. | 35 | $565 |
| Pfizer | 37 | $502 |
| Nevro Corp. | 6 | $246 |
| Biohaven Pharmaceutical Holding Company Ltd. | 19 | $231 |
| Biohaven Pharmaceuticals, Inc. | 21 | $199 |
| SPR Therapeutics, Inc | 3 | $186 |
| Amgen | 9 | $142 |
| Boston Scientific | 7 | $135 |
| Vertex | 6 | $111 |
| Curonix LLC | 4 | $99 |
| Biodelivery Sciences International, Inc. | 5 | $82 |
| Averitas Pharma Inc. | 5 | $81 |
| Lilly USA, LLC | 5 | $77 |
| Almatica Pharma LLC | 3 | $63 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $53 |
| GRT US Holding, Inc. | 3 | $51 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Abbott | 2 | $33 |
| Lundbeck LLC | 1 | $24 |
| Saluda Medical Americas, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| Tonix Medicines, Inc. | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Orexo US, Inc. | 1 | $13 |
| Protega Pharmaceutials Inc | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$871
- INTELLIS ADAPTIVESTIM$265
- SPRINT PNS System$161
- INCEPTIV$141
- Senza$115
How this compares
$7,259 in reported general payments places this provider in the 95th percentile of 88 hospice and palliative medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 52 | $36,762 |
| BelbucaBuprenorphine Hcl | 68 | $32,507 |
| UbrelvyUbrogepant | 14 | $32,142 |
| Xtampza ErOxycodone Myristate | 33 | $27,301 |
| Nurtec OdtRimegepant Sulfate | 12 | $23,589 |
| QuliptaAtogepant | 17 | $18,054 |
| Buprenorphine | 70 | $17,517 |
| MovantikNaloxegol Oxalate | 25 | $13,370 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 463 | $12,937 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $12,327 |
| Pregabalin | 267 | $11,022 |
| Oxycodone Hcl | 432 | $9,239 |
| Emgality SyringeGalcanezumab-Gnlm | 12 | $8,433 |
| Gabapentin | 497 | $7,615 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 340 | $6,490 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $565 | $59,808101 claims |
| AbbVieUbrelvy, Qulipta | $1,424 | $50,19531 claims |
| PfizerNurtec Odt | $502 | $23,58912 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl | $42 | $22,760145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 88 hospice and palliative medicine providers in Ohio.
Other hospice and palliative medicine in Columbus
- Michael PattersonColumbus$7K
- Amit PatelColumbus$7K
- Joseph TuColumbus$5K
- Saurabh KhuranaColumbus$3K
- David LaubliColumbus$678
- Jessica MerlinColumbus$550
- Gregg WeidnerColumbus$434
- Tommy PetrosColumbus$431
- Charles MillerColumbus$213
- Kavita ShahColumbus$203
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.